Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 29, Issue 10

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 29, Issue 10 (2020)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 29, Issue 10 (2020)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Volume 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

DRUG EVALUATION

Article

Melflufen for relapsed and refractory multiple myeloma

Albert Oriol, Alessandra Larocca, Xavier Leleu, Roman Hajek, Hani Hassoun, Paula Rodríguez-Otero, Agne Paner, Fredrik H. Schjesvold, Joachim Gullbo & Paul G. Richardson

Pages: 1069-1078

Published online: 29 Sep 2020

AbstractforMelflufen for relapsed and refractory multiple myeloma | Full Text | References | PDF (1,004.7 KB) | EPUB

3939 Views
14 CrossRef citations
0Altmetric

Open Access

Drug Evaluation

Article

Polatuzumab vedotin: an investigational anti-CD79b antibody drug conjugate for the treatment of diffuse large B-cell lymphoma

Estelle Bourbon & Gilles Salles

Pages: 1079-1088

Published online: 12 Aug 2020

AbstractforPolatuzumab vedotin: an investigational anti-CD79b antibody drug conjugate for the treatment of diffuse large B-cell lymphoma | Full Text | References | PDF (1 MB) | EPUB

1473 Views
12 CrossRef citations
0Altmetric

Article

Baricitinib: therapeutic potential for moderate to severe atopic dermatitis

Laura Calabrese, Dalma Malvaso, Andrea Chiricozzi, Sara Tambone, Dario Francesco D’Urso, Cristina Guerriero & Ketty Peris

Pages: 1089-1098

Published online: 14 Aug 2020

AbstractforBaricitinib: therapeutic potential for moderate to severe atopic dermatitis | Full Text | References | PDF (1.8 MB) | EPUB

587 Views
6 CrossRef citations
0Altmetric

Review

New drugs on the horizon for cerebral edema: what’s in the clinical development pipeline?

Stephanie M. Robert, Benjamin C. Reeves, Seth L. Alper, Jinwei Zhang & Kristopher T. Kahle

Pages: 1099-1105

Published online: 20 Sep 2020

AbstractforNew drugs on the horizon for cerebral edema: what’s in the clinical development pipeline? | Full Text | References | PDF (337 KB) | EPUB

172 Views
5 CrossRef citations
0Altmetric

Cystic fibrosis – Ten promising therapeutic approaches in the current era of care

Ranjani Somayaji, Dave P Nichols & Scott C Bell

Pages: 1107-1124

Published online: 10 Oct 2020

AbstractforCystic fibrosis – Ten promising therapeutic approaches in the current era of care | Full Text | References | PDF (3.6 MB) | EPUB

1331 Views
7 CrossRef citations
0Altmetric

Huntingtin-lowering strategies for Huntington’s disease

Roger A. Barker, Motoki Fujimaki, Priya Rogers & David C. Rubinsztein

Pages: 1125-1132

Published online: 14 Aug 2020

AbstractforHuntingtin-lowering strategies for Huntington’s disease | Full Text | References | PDF (1.3 MB) | EPUB

1261 Views
18 CrossRef citations
0Altmetric

Proteasome inhibition for the treatment of glioblastoma

Patrick Roth, Warren P. Mason, Paul G. Richardson & Michael Weller

Pages: 1133-1141

Published online: 10 Aug 2020

AbstractforProteasome inhibition for the treatment of glioblastoma | Full Text | References | PDF (1.2 MB) | EPUB

539 Views
23 CrossRef citations
0Altmetric

Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis

Sebastian Torke & Martin S. Weber

Pages: 1143-1150

Published online: 19 Aug 2020

AbstractforInhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis | Full Text | References | PDF (1.3 MB) | EPUB

2698 Views
33 CrossRef citations
0Altmetric

Systemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development

Milena Tocut, Yehuda Shoenfeld & Gisele Zandman-Goddard

Pages: 1151-1162

Published online: 14 Aug 2020

AbstractforSystemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development | Full Text | References | PDF (2.3 MB) | EPUB

403 Views
6 CrossRef citations
0Altmetric

Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases

Kanmin Xue & Robert E. MacLaren

Pages: 1163-1170

Published online: 01 Sep 2020

AbstractforAntisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases | Full Text | References | PDF (1.7 MB) | EPUB

8794 Views
40 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol

Amanda J. Hooper et al.

Editorial | Published online: 21 Jun 2024

Free Access

Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs

Lorenza Magagnoli et al.

Review Article | Published online: 19 Jun 2024

Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development

Luca Iorio et al.

Report | Published online: 16 Jun 2024

Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study

Ling Yang et al.

Article | Published online: 3 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.29, Iss.10, 2020)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?